MedTrace Logo

A Single Dose FMT Infusion as an Adjunct to Keytruda for Metastatic Mesothelioma

NCT04056026 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2019-09-23

No results posted yet for this study

Summary

The investigators propose to ensure a favorable gut microbiome by fecal microbiota transplant to enhance the efficacy Keytruda

Conditions

Interventions

BIOLOGICAL

Fecal Microbiota Transplant

Fecal material from a healthy family donor will be transplanted into the patient via colonoscopy

Sponsors & Collaborators

  • ProgenaBiome

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-18
Primary Completion
2018-12-18
Completion
2018-12-18
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04056026 on ClinicalTrials.gov